Get started Log in

4521 — KAKEN PHARMACEUTICAL Share News

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapNeutral

Market Cap
¥145bn
Enterprise Value
¥91bn
Revenue
¥77bn

Brief: Kaken Pharmaceutical Says It Will Buy Back Up To 0.9% Of Own Shares Worth 1.5 Billion Yen
11/05/2022 05:35
Table: Kaken Pharmaceutical -2021/22 group results
11/05/2022 05:30
Table: Kaken Pharmaceutical -2021/22 group forecast
29/03/2022 08:15
Table: Kaken Pharmaceutical - 9-MTH group results
07/02/2022 17:54
Table: Kaken Pharmaceutical - 9-MTH group results
03/02/2022 04:30
Table: Kaken Pharmaceutical - 6-MTH group results
04/11/2021 04:30
Table: Kaken Pharmaceutical -Q1 group results
03/08/2021 05:30
Brief: Almirall And Kaken Pharmaceutical Enter Into Agreement For European Rights To Topical Formulation Of Efinaconazole
01/07/2021 07:32
Table: Kaken Pharmaceutical -2020/21 group results
07/05/2021 05:30
Table: Kaken Pharmaceutical - 9-MTH group results
03/02/2021 04:30
Table: Kaken Pharmaceutical - 6-MTH group results
05/11/2020 04:30
Table: Kaken Pharmaceutical -2020/21 group forecast
27/10/2020 06:30
2020 6-month group forecast
27/10/2020 06:30
Table: Kaken Pharmaceutical -Q1 group results
03/08/2020 05:30
Table: Kaken Pharmaceutical -2019/20 group results
22/05/2020 06:30
Table: Kaken Pharmaceutical -2019/20 group forecast
27/03/2020 07:30
Table: Kaken Pharmaceutical - 9-MTH group results
03/02/2020 04:30
Table: Kaken Pharmaceutical - 6-MTH group results
06/11/2019 04:30
Table: Kaken Pharmaceutical -Q1 group results
01/08/2019 05:30
Table: Kaken Pharmaceutical -2018/19 group results
09/05/2019 05:30